[Retracted] Efficacy of Duhuo Jisheng Decoction in Treating Ankylosing Spondylitis: Clinical Evidence and Potential Mechanisms

Table 1

Demographic and clinical characteristics of the included studies.

Author, year	Sample size (I/C)	Age (years) (I/C)	Intervention	Control	Period of treatment
Sun et al., [15]	55/56	33.6 ± 12.9/34.4 ± 13.2	Duhuo Jisheng Decoction	Meloxicam tablets + sulfasalazine tablets	4 m
Zhang et al., [16]	58/60	18–45/13–48	Duhuo Jisheng Decoction	Naphtobumethone tablets + sulfasalazine tablets	1 m
Dong [17]	50/50	35.62 ± 9.53/36.32 ± 9.66	Duhuo Jisheng Decoction	Meloxicam tablets + sulfasalazine tablets	1 m
Yan et al., [18]	32/28	37.54 ± 13.67/38.25 ± 12.94	Duhuo Jisheng Decoction	Indometacin + sulfasalazine tablets	2 m
Pan et al., [19]	39/39	33 ± 15/36 ± 14	Duhuo Jisheng decoction	Meloxicam tablets + sulfasalazine tablets	2 m
Yu et al., [20]	52/40	33.28 ± 5.27/32.16 ± 4.89	Duhuo Jisheng decoction	Diclofenac sodium + sulfasalazine tablets	24 w
Zuo et al., [21]	42/45	33.76 ± 6.74/32.83 ± 7.12	Duhuo Jisheng decoction	Methotrexate tablets + sulfasalazine tablets	3 w
Lu [22]	30/30	43.23 ± 4.10/42.12 ± 4.01	Duhuo Jisheng decoction	Meloxicam tablets + sulfasalazine tablets	3 m
Zhou [23]	36/31	18–50/17–49	Duhuo Jisheng decoction	Indometacin + sulfasalazine tablets	3 m
Yang [24]	42/45	33.76 ± 6.74/32.83 ± 7.12	Duhuo Jisheng decoction	Methotrexate tablets + sulfasalazine tablets	3 m

I, intervention; C, control; M, month; W, week.